AMPK activator 11 is used for anticancer and metabolic disease research; it exhibits nanomolar-level antitumor activity against multiple colorectal cancers (CRC) and selectively inhibits the growth of RKO xenografts by activating AMPK and upregulating oxidative phosphorylation (OXPHOS) in mitochondrial metabolism.